“gene-therapy” Archives

in
Entry Author Date Location
Fresh Off ASH Data, Spark Teams With Selecta to Boost Gene Therapies 12/05/16 Boston
Struggling UniQure Cuts Gene Therapies, Jobs, in Big Restructuring 11/15/16 Boston
Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More 11/04/16 National
New Data Show Power, Limits of Bluebird’s Gene Therapy For Blood Diseases 11/03/16 Boston
Bio Roundup: Bristol & Illumina Blues, Sickle Cell News & More 10/14/16 National
With Upgraded Tech, Bluebird Updates Regulatory Path For Gene Therapy 10/13/16 Boston
Seeking to Join Editas, Intellia, CRISPR Tx Makes Long Awaited IPO Push 09/12/16 Boston
Allergan Dips Toes into Gene Therapy With $60M Retrosense Buy 09/06/16 Detroit Ann Arbor
Novartis Disbands T Cell Group But Promises To Press Ahead In CAR-T Race 08/31/16 National
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
Shire Steps Back in Hemophilia Gene Therapy Race, Scraps Baxalta Drug 08/03/16 Boston
Biotech Roundup: Gilead Slump, Celgene Goes Trump, Hemo Data & More 07/29/16 National
At Big Hemophilia Meeting, More Data, and Promise, For Gene Therapy 07/28/16 National
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
Audentes Prices $75M IPO As Gene Therapy Eyes First U.S. Approval 07/20/16 San Francisco
Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More 07/01/16 National
The Biotech Roundup: Immunotherapy Ups And Downs, Gene Deals & More 05/20/16 National
Spark Adds To Early But Promising Data For Hemophilia Gene Therapy 05/19/16 National
Biogen Turns To UPenn Gene Therapy Pioneers in Wide-Ranging Alliance 05/16/16 Boston
East Coast Biotech Roundup: Homology, Biogen, Intellia & More 05/05/16 Boston
With $43.5M Startup Cash, Homology Med Chases New Gene Editing Twist 05/02/16 Boston
West Coast Bio Roundup: Prince, Theranos, Second Genome, CytomX & More 04/22/16 San Francisco
With BioMarin Data, Gene Therapy Finally Shows Impact on Hemophilia A 04/20/16 San Francisco
Bluebird’s Gene Therapy Shows Promise in Rare Brain Disease 04/20/16 Boston
Gene Editing Execs Talk Scientific, Regulatory Hurdles At BIO Panel 02/10/16 Boston
West Coast Bio Roundup: Tessier-Lavigne, Twist, Unity, Grail & More 02/05/16 San Francisco
East Coast Bio Roundup: CRISPR, Tessier-Lavigne, Pricing, Spero & More 02/05/16 Boston
CRISPR Hits Wall Street as Editas Bags $94M in IPO 02/02/16 Boston
CRISPR: The Path to Clinical Trials 01/29/16 Boston
Grail’s Discount, Pfizergan & Pricing Plans: Notes from the JPM Vortex 01/15/16 National
Page 1 of 7 next page »